“Clarification: For case 1, the negative spinal fluid SARS-CoV-2 antibody tests (WONDFO and cPASS) evaluated both IgM and IgG, not just IgG alone. And these were done on both day 30 and 37, not just at day 37.” The tests were not specifically validated for spinal fluid.
. 2021 Oct 28;25:100373. doi: 10.1016/j.ensci.2021.100373
Corrigendum to “Encephalopathy in COVID-19 patients; viral, parainfectious, or both?” [eNeurologicalScic(Volume 21), December 2020, 100275]
Thirugnanam Umapathi
a,⁎, Wei Ming Jason Quek
b, Jia Min Yen
b, Hnin Su Wai Khin
a, Yun Yuan Mah
b, Chee Yee Joel Chan
b, Li Min Ling
b, Wai-Yung Yu
a
Thirugnanam Umapathi
aNational Neuroscience Institute, Singapore
Find articles by Thirugnanam Umapathi
aNational Neuroscience Institute, Singapore
bTan Tock Seng Hospital, Singapore
⁎
Corresponding author. umapathi@nni.com.sg
Collection date 2021 Dec.
© 2021 The Author(s)
PMCID: PMC8552629 PMID: 34729425
This corrects the article "Encephalopathy in COVID-19 patients; viral, parainfectious, or both?" in volume 21, 100275.